Cargando…
Primary mediastinal large B-cell lymphoma: transcriptional regulation by miR-92a through FOXP1 targeting
BACKGROUND: Primary mediastinal large B-cell lymphoma (PMBL) shares pathological features with diffuse large B-cell lymphoma (DLBCL), and molecular features with classical Hodgkin lymphoma (cHL). The miR-17∼92 oncogenic cluster, located at chromosome 13q31, is a region that is amplified in DLBCL. ME...
Autores principales: | Romero, Martha, Gapihan, Guillaume, Castro-Vega, Luis Jaime, Acevedo, André, Wang, Li, Li, Zhao Wei, El Bouchtaoui, Morad, Di Benedetto, Ménie, Ratajczak, Philippe, Feugeas, Jean-Paul, Thieblemont, Catherine, Saavedra, Carlos, Janin, Anne |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5369960/ https://www.ncbi.nlm.nih.gov/pubmed/27806315 http://dx.doi.org/10.18632/oncotarget.12988 |
Ejemplares similares
-
Targeting Cancer Stem Cells to Overcome Chemoresistance
por: Nunes, Toni, et al.
Publicado: (2018) -
EGFR is involved in dermatofibrosarcoma protuberans progression to high grade sarcoma
por: Osio, Amélie, et al.
Publicado: (2018) -
Increased risk of brain metastases among patients with melanoma and PROM2 expression in metastatic lymph nodes
por: Nguyen, Thuy Thi, et al.
Publicado: (2020) -
High expression of apoptosis protein (Api-5) in chemoresistant triple-negative breast cancers: an innovative target
por: Bousquet, Guilhem, et al.
Publicado: (2019) -
Metastatic clear-cell renal cell carcinoma: a frequent NOTCH1 mutation predictive of response to anti-NOTCH1 CB-103 treatment
por: Bui, Thi Oanh, et al.
Publicado: (2023)